DURHAM, N.C. & SEATTLE--January 12, 2025--Leading epigenome editing company Tune Therapeutics (Tune) today announced the completion of over $175M in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures and...
Jeff Collins to sit on a panel titled "Investing in Neurotech" at The Neurotech Industry Investing and Partnering Conference in Boston, MA
News | 05. 08. 2008
